Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion

被引:46
作者
Butrapet, Siritorn
Childers, Thomas
Moss, Kelley J.
Erb, Steven M. [2 ]
Luy, Betty E.
Calvert, Amanda E.
Blair, Carol D. [2 ]
Roehrig, John T.
Huang, Claire Y. -H. [1 ]
机构
[1] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Dis, Ft Collins, CO 80521 USA
[2] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA
关键词
Dengue virus; Flavivirus; Hinge; Fusion; Envelope protein; Mutagenesis; YELLOW-FEVER VIRUS; VALLEY ENCEPHALITIS-VIRUS; FLAVIVIRUS ENVELOPE GLYCOPROTEIN; FRENCH NEUROTROPIC VACCINE; ENDOCYTIC PATHWAY; MEMBRANE-FUSION; CELL-LINE; STRAIN; NEUROINVASIVENESS; NEUROVIRULENCE;
D O I
10.1016/j.virol.2011.01.030
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Fifteen mutant dengue viruses were engineered and used to identify AAs in the molecular hinge of the envelope protein that are critical to viral infection. Substitutions at Q52, A54, or E133 reduced infectivity in mammalian cells and altered the pH threshold of fusion. Mutations at F193, G266,1270, or G281 affected viral replication in mammalian and mosquito cells, but only I270W had reduced fusion activity. T280Y affected the pH threshold for fusion and reduced replication in C6/36 cells. Three different mutations at L135 were lethal in mammalian cells. Among them, L135G abrogated fusion and reduced replication in C6/36 cells, but only slightly reduced the mosquito infection rate. Conversely, L135W replicated well in C6/36 cells, but had the lowest mosquito infection rate. Possible interactions between hinge residues 52 and 277, or among 53, 135, 170, 186, 265, and 276 required for hinge function were discovered by sequence analysis to identify compensatory mutations. Published by Elsevier Inc.
引用
收藏
页码:118 / 127
页数:10
相关论文
共 40 条
[1]   Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies [J].
Beasley, DWC ;
Aaskov, JG .
VIROLOGY, 2001, 279 (02) :447-458
[2]   The effects of midgut serine proteases on dengue virus type 2 infectivity of Aedes aegypti [J].
Brackney, Doug E. ;
Foy, Brian D. ;
Olson, Ken E. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (02) :267-274
[3]   Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence [J].
Bray, M ;
Men, R ;
Tokimatsu, I ;
Lai, CJ .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1647-1651
[4]   Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation [J].
Bressanelli, S ;
Stiasny, K ;
Allison, SL ;
Stura, EA ;
Duquerroy, S ;
Lescar, J ;
Heinz, FX ;
Rey, FA .
EMBO JOURNAL, 2004, 23 (04) :728-738
[5]   Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA [J].
Butrapet, S ;
Kinney, RA ;
Huang, CYH .
JOURNAL OF VIROLOGICAL METHODS, 2006, 131 (01) :1-9
[6]   NUCLEOTIDE CHANGES RESPONSIBLE FOR LOSS OF NEUROINVASIVENESS IN JAPANESE ENCEPHALITIS-VIRUS NEUTRALIZATION-RESISTANT MUTANTS [J].
CECILIA, D ;
GOULD, EA .
VIROLOGY, 1991, 181 (01) :70-77
[7]   Neuroadapted yellow fever virus 17D: Genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone [J].
Chambers, TJ ;
Nickells, M .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10912-10922
[8]   Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway [J].
Chu, JJH ;
Ng, ML .
JOURNAL OF VIROLOGY, 2004, 78 (19) :10543-10555
[9]   Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes [J].
Crill, WD ;
Chang, GJJ .
JOURNAL OF VIROLOGY, 2004, 78 (24) :13975-13986
[10]   Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus [J].
dos Santos, CND ;
Frenkiel, MP ;
Courageot, MP ;
Rocha, CFS ;
Vazeille-Falcoz, MC ;
Wien, MW ;
Rey, FA ;
Deubel, V ;
Desprès, P .
VIROLOGY, 2000, 274 (02) :292-308